Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PHIO Phio Pharmaceuticals

交易中 11-05 12:41:00 EST

3.26

+0.05

+1.56%

最高3.33	最低3.05	成交量1.02万
今开3.13	昨收3.21	日振幅8.72%
总市值280.60万	流通市值178.59万	总股本86.07万
成交额3.30万	换手率1.87%	流通股本54.78万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PHIO","market":"US","secType":"STK","nameCN":"Phio Pharmaceuticals","latestPrice":3.26,"timestamp":1730828232456,"preClose":3.21,"halted":0,"volume":10238,"delay":0,"floatShares":547831,"shares":860721,"eps":-21.34513,"marketStatus":"交易中","marketStatusCode":2,"change":0.05,"latestTime":"11-05 12:41:00 EST","open":3.13,"high":3.33,"low":3.05,"amount":33017.524405000004,"amplitude":0.087227,"askPrice":3.26,"askSize":200,"bidPrice":3.22,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-21.34513,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1730840400000},"adr":0,"adjPreClose":3.21,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":3.21,"preClose":3.21,"latestTime":"19:09 EST","volume":30,"amount":93.8,"timestamp":1730765380200},"volumeRatio":0.499302,"impliedVol":2.2675,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/PHIO","defaultTab":"news","newsList":[{"id":"2480063928","title":"Phio Pharmaceuticals Corp.盘中异动 股价大跌7.62%报2.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480063928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480063928?lang=zh_cn&edition=full","pubTime":"2024-11-01 03:13","pubTimestamp":1730401992,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日03时13分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅下跌7.62%。截至发稿，该股报2.91美元/股，成交量2.598万股，换手率3.02%，振幅6.03%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为3.38%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110103131298e3fc94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110103131298e3fc94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2479860277","title":"Phio Pharmaceuticals Corp.盘中异动 大幅下跌5.77%报3.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479860277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479860277?lang=zh_cn&edition=full","pubTime":"2024-10-30 22:12","pubTimestamp":1730297550,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日22时12分，Phio Pharmaceuticals Corp.股票出现异动，股价大幅跳水5.77%。截至发稿，该股报3.10美元/股，成交量2.0807万股，换手率2.42%，振幅5.62%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.10%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103022123098e3f6f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103022123098e3f6f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2479430552","title":"Phio Pharmaceuticals Corp.盘中异动 急速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479430552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479430552?lang=zh_cn&edition=full","pubTime":"2024-10-29 01:42","pubTimestamp":1730137324,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日01时42分，Phio Pharmaceuticals Corp.股票出现异动，股价大幅上涨5.15%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.11%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029014204a1f2c52e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029014204a1f2c52e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2478930251","title":"Phio Pharmaceuticals Corp.盘中异动 临近午盘急速下跌8.45%报2.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478930251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478930251?lang=zh_cn&edition=full","pubTime":"2024-10-25 23:34","pubTimestamp":1729870441,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日23时34分，Phio Pharmaceuticals Corp.股票出现异动，股价急速跳水8.45%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Iterum Therapeutics Plc、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Immunitybio, Inc.涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为775.94%、733.42%、203.67%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Iterum Therapeutics Plc、Elevai Labs, Inc.，振幅分别为91.58%、90.60%、85.14%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102523340195bd5a54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102523340195bd5a54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2477653638","title":"Phio Pharmaceuticals Corp.盘中异动 股价大涨5.33%报3.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477653638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477653638?lang=zh_cn&edition=full","pubTime":"2024-10-24 22:58","pubTimestamp":1729781912,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日22时58分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅上涨5.33%。截至发稿，该股报3.09美元/股，成交量3829股，换手率0.44%，振幅3.41%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.22%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024225833ab70d3dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024225833ab70d3dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2477536970","title":"Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌6.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477536970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477536970?lang=zh_cn&edition=full","pubTime":"2024-10-23 22:10","pubTimestamp":1729692616,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日22时10分，Phio Pharmaceuticals Corp.股票出现波动，股价急速下挫6.71%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为1.19%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102322101798e3e02b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102322101798e3e02b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2477869822","title":"Phio Pharmaceuticals Corp.盘中异动 股价大涨5.50%报3.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477869822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477869822?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:04","pubTimestamp":1729519473,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时04分，Phio Pharmaceuticals Corp.股票出现波动，股价快速上涨5.50%。截至发稿，该股报3.07美元/股，成交量6673股，换手率0.78%，振幅1.00%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.10%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021220433a1e24b4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021220433a1e24b4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2476411258","title":"Phio Pharmaceuticals Corp.盘中异动 大幅上涨7.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476411258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476411258?lang=zh_cn&edition=full","pubTime":"2024-10-18 21:32","pubTimestamp":1729258347,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日21时32分，Phio Pharmaceuticals Corp.股票出现异动，股价快速拉升7.17%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.16%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410182132279f4d89c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410182132279f4d89c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2476718501","title":"Phio Pharmaceuticals Corp.盘中异动 早盘急速下跌6.46%报3.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476718501","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476718501?lang=zh_cn&edition=full","pubTime":"2024-10-17 22:18","pubTimestamp":1729174712,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日22时18分，Phio Pharmaceuticals Corp.股票出现异动，股价大幅下挫6.46%。截至发稿，该股报3.04美元/股，成交量2.0298万股，换手率2.36%，振幅6.18%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.70%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017221832971a0dc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017221832971a0dc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2475477659","title":"Phio Pharmaceuticals Corp.盘中异动 股价大涨5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475477659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475477659?lang=zh_cn&edition=full","pubTime":"2024-10-16 01:25","pubTimestamp":1729013153,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日01时25分，Phio Pharmaceuticals Corp.股票出现异动，股价快速上涨5.81%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.06%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016012553a1e0ddce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016012553a1e0ddce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2474729641","title":"Phio Pharmaceuticals Corp.盘中异动 快速下跌8.30%报2.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474729641","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474729641?lang=zh_cn&edition=full","pubTime":"2024-10-11 00:20","pubTimestamp":1728577214,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日00时20分，Phio Pharmaceuticals Corp.股票出现波动，股价急速跳水8.30%。截至发稿，该股报2.65美元/股，成交量1.6677万股，换手率1.94%，振幅4.50%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.53%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410110020149719f8ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410110020149719f8ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2474205302","title":"Phio Pharmaceuticals Corp.盘中异动 急速拉升5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474205302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474205302?lang=zh_cn&edition=full","pubTime":"2024-10-09 23:10","pubTimestamp":1728486607,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日23时10分，Phio Pharmaceuticals Corp.股票出现波动，股价快速拉升5.34%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.07%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009231010a1df6f75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009231010a1df6f75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2473027101","title":"Phio Pharmaceuticals Corp.盘中异动 快速跳水6.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473027101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473027101?lang=zh_cn&edition=full","pubTime":"2024-10-07 22:40","pubTimestamp":1728312033,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日22时40分，Phio Pharmaceuticals Corp.股票出现异动，股价急速跳水6.82%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.24%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072240339719eaaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410072240339719eaaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2472697574","title":"Phio Pharmaceuticals Corp.盘中异动 股价大跌5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472697574","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472697574?lang=zh_cn&edition=full","pubTime":"2024-10-03 01:17","pubTimestamp":1727889443,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日01时17分，Phio Pharmaceuticals Corp.股票出现波动，股价急速跳水5.47%。截至发稿，该股报3.21美元/股，成交量1.5039万股，换手率1.75%，振幅7.46%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为1.00%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410030117239719e00d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410030117239719e00d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2471338536","title":"Phio Pharmaceuticals Corp.盘中异动 股价大涨5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2471338536","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471338536?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:37","pubTimestamp":1727703436,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时37分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅拉升5.43%。截至发稿，该股报3.69美元/股，成交量2116股，换手率0.25%，振幅1.84%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.06%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024093021371698e39d6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024093021371698e39d6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2470629247","title":"Phio Pharmaceuticals Corp.盘中异动 大幅上涨6.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470629247","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470629247?lang=zh_cn&edition=full","pubTime":"2024-09-27 03:58","pubTimestamp":1727380681,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日03时58分，Phio Pharmaceuticals Corp.股票出现波动，股价急速上涨6.27%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.26%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927035801a1dccb43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927035801a1dccb43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2470410262","title":"Phio Pharmaceuticals Corp.盘中异动 临近午盘快速上涨5.56%报3.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470410262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470410262?lang=zh_cn&edition=full","pubTime":"2024-09-25 23:44","pubTimestamp":1727279044,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日23时44分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅上涨5.56%。截至发稿，该股报3.61美元/股，成交量2.2861万股，换手率2.66%，振幅7.46%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.36%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092523440498e38e85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092523440498e38e85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2468057770","title":"Phio Pharmaceuticals Corp.盘中异动 早盘急速下跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468057770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468057770?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:48","pubTimestamp":1726753703,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时48分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅跳水5.17%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为1703.54%、470.56%、83.09%，振幅较大的相关个股有Exicure, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Galmed Pharmaceuticals Ltd.，振幅分别为74.67%、52.97%、46.23%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919214823ab64a322&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919214823ab64a322&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2460059229","title":"Phio Pharmaceuticals Corp.盘中异动 临近午盘急速上涨5.37%报3.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460059229","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460059229?lang=zh_cn&edition=full","pubTime":"2024-08-19 23:44","pubTimestamp":1724082292,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日23时44分，Phio Pharmaceuticals Corp.股票出现波动，股价急速上涨5.37%。截至发稿，该股报3.14美元/股，成交量3.9637万股，换手率7.77%，振幅5.70%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为1.42%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819234452971992c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819234452971992c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2460249971","title":"Phio Pharmaceuticals Corp.盘中异动 临近午盘股价大涨10.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460249971","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460249971?lang=zh_cn&edition=full","pubTime":"2024-08-16 23:54","pubTimestamp":1723823689,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日23时54分，Phio Pharmaceuticals Corp.股票出现异动，股价快速上涨10.47%。截至发稿，该股报2.85美元/股，成交量5327股，换手率1.04%，振幅7.36%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.17%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081623544997198fb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081623544997198fb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.phiopharma.com","stockEarnings":[{"period":"1week","weight":0.0664},{"period":"1month","weight":0.0422},{"period":"3month","weight":0.1383},{"period":"6month","weight":-0.5542},{"period":"1year","weight":-0.7318},{"period":"ytd","weight":-0.5307}],"compareEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.0913},{"period":"6month","weight":0.1017},{"period":"1year","weight":0.3108},{"period":"ytd","weight":0.1988}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Phio Pharmaceuticals Corp.是一家生物技术公司，基于公司专有的新一代核糖核酸干扰(RNAi)平台专注于发现、开发和商业化创新疗法。由于这些疗法得“沉默”能力,或者说是其下调能力,病态情况下的特定基因可以被分析的更为清楚，所以基于RNAi平台的疗法更有说服力的。2011年9月8日之前,该公司的业务由其非操作部门Galena Biopharma公司（该公司的前母公司）来完成。公司成立于特拉华州，作为Galena 的全资子公司。2011年9月8日开始，其计划并准备与Galena脱离。2012年4月27日这一计划得以完成。至此之后,公司作为一个独立的上市公司运营。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":-0.062312},{"month":2,"riseRate":0.4,"avgChangeRate":-0.033019},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.080586},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.121062},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.038426},{"month":6,"riseRate":0.454545,"avgChangeRate":-0.020605},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.103097},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.030187},{"month":9,"riseRate":0.090909,"avgChangeRate":-0.131629},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.131123},{"month":11,"riseRate":0.454545,"avgChangeRate":-0.048388},{"month":12,"riseRate":0.2,"avgChangeRate":-0.125431}],"exchange":"NASDAQ","name":"Phio Pharmaceuticals","nameEN":"Phio Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Phio Pharmaceuticals(PHIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Phio Pharmaceuticals,PHIO,Phio Pharmaceuticals股票,Phio Pharmaceuticals股票老虎,Phio Pharmaceuticals股票老虎国际,Phio Pharmaceuticals行情,Phio Pharmaceuticals股票行情,Phio Pharmaceuticals股价,Phio Pharmaceuticals股市,Phio Pharmaceuticals股票价格,Phio Pharmaceuticals股票交易,Phio Pharmaceuticals股票购买,Phio Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Phio Pharmaceuticals(PHIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}